Background
==========

Recent work has highlighted interplay between components of the Fanconi anemia (FA) pathway, an inherited genome instability syndrome characterized by hypersensitivity to DNA interstrand cross-links (ICLs), and the breast cancer susceptibility proteins BRCA1 and BRCA2/FANCD1. Is has also been suggested that certain defects within FANCD2, which is the central factor in the FA pathway, may lead to an increased risk of sporadic breast cancer.

Methods
=======

Mass spectrometry and candidate western blotting analyses were carried out on FCD-2 immunoprecipitates from untreated and cisplatin-treated whole worm extracts.

Results
=======

Using the nematode worm as a model system, we have identified the circadian protein CLK-2 and ATL-1 (*C. elegans*ATR) as factors that coimmunoprecipitate with *C. elegans*FANCD2 (FCD-2) following ICL damage. *C. elegans atl-1*and *clk-2*mutants and siRNA depletion of human hCLK2 (KIAA00693) compromises FCD-2/FANCD2 recruitment to blocked replication forks and confers ICL sensitivity, a hallmark of FA. Cells deficient for hCLK2 are also defective for damage-induced mono-ubiquitylation of FANCD2 and exhibit radio-resistant DNA synthesis indicative of an S-phase checkpoint defect. ATR activation leading to BRCA1-mediated ubiquitylation remains intact in hCLK2 depleted cells, yet ATR-dependent phosphorylation of Chk1 and Claspin is severely attenuated following S-phase insults. Finally, recruitment of the homologous recombination factor RAD51 is also impaired in cells depleted of hCLK2, which leads to a reduced homologous recombination frequency at sites of DNA damage.

Conclusion
==========

These data indicate that the novel factor hCLK2 is an essential component of the mammalian S-phase checkpoint required to coordinate both FA and HR-mediated repair responses following replication stress.
